SCHEMBL2020995

SCHEMBL2020995

CC1CN(Cc2ccc(Nc3ncc4cc(C(=O)N(C)C)n(C5CCCC5)c4n3)nc2)CCN1C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 8/20 0.76
CDK2 P24941 4/20 0.76
CDK4 P11802 14/20 0.63
CCND1 P24385 2/20 0.59
GAK O14976 1/20 0.59
CCNT1 O60563 1/20 0.59
CCNA2 P20248 1/20 0.59
FECH P22830 1/20 0.59
CCND3 P30281 1/20 0.59
CDK9 P50750 1/20 0.59
CDK6 Q00534 1/20 0.59
CDK16 Q00536 1/20 0.59
MAP3K1 Q13233 1/20 0.59
CAMK2G Q13555 1/20 0.59
CAMK2D Q13557 1/20 0.59
Q6ZSR9 Q6ZSR9 1/20 0.59
PRKD2 Q9BZL6 1/20 0.59
SIK2 Q9H0K1 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2020992 1.00 CDK1 (0.76) CDK1CDK2CDK4CCND1GAK
SCHEMBL1992081 0.90 CDK1 (0.70) CDK1CDK2CDK4CCND1GAK
SCHEMBL1997275 0.90 CDK1 (0.70) CDK1CDK2CDK4CCND1GAK
SCHEMBL1990001 0.87 CDK1 (0.81) CDK1CDK2CDK4CCND1GAK
SCHEMBL30729679 0.87 CDK1 (0.78) CDK1CDK2CDK4CCND1GAK
SCHEMBL30176575 0.87 CDK1 (0.78) CDK1CDK2CDK4CCND1GAK
SCHEMBL1995145 0.87 CDK1 (0.78) CDK1CDK2CDK4CCND1GAK
SCHEMBL30729678 0.87 CDK1 (0.78) CDK1CDK2CDK4CCND1GAK
SCHEMBL302279 0.87 CDK1 (0.78) CDK1CDK2CDK4CCND1GAK
SCHEMBL2023942 0.87 CDK4 (0.76) CDK1CDK2CDK4CCND1GAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331547-A1 PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS Novartis AG (CH) 2011-06-15 EP disclosed
WO-2010020675-A1 PYRROLOPYRIMIDINE COMPOUNDS AS CDK INHIBITORS NOVARTIS AG (CH) 2010-02-25 WO disclosed